Showing results (1371-1380 of 1,801) with videos related to
Sort By:
Pageof 181
BMJ Open Ophthalmology|January 23, 2018
Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical studyDietmar Schwab, Carolina Sturm, Agnès Portron, et al.European Journal of Ophthalmology|December 28, 2006
The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucomaG Holló, D Chiselita, N Petkova, et al.Immunology|February 1, 1989
The distribution of immunoreactive interferon-alpha in normal human tissuesN U Khan, K A Pulford, M A Farquharson, et al.Acta Ophthalmologica|January 31, 2009
Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucomaAnastasios G P Konstas, Sevasti Tsironi, Athanasios N Vakalis, et al.Journal of Medicinal Chemistry|June 16, 2017
Synthesis and Preclinical Characterization of a Cationic Iodinated Imaging Contrast Agent (CA4+) and Its Use for Quantitative Computed Tomography of Ex Vivo Human Hip CartilageRachel C Stewart, Amit N Patwa, Hrvoje Lusic, et al.American Journal of Ophthalmology|August 6, 2000
Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressureW C Stewart, E D Sharpe, T S Harbin, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 2, 2001
Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertensionW C Stewart, D G Day, J A Stewart, et al.Journal of Bioethical Inquiry|September 11, 2025
Commercial Impacts on Assisted Reproductive Technology: A Scoping ReviewM Wiersma, I Kerridge, S Gallagher, et al.Microbiology (Reading, England)|August 8, 1998
Actin enhances the haemolytic activity of Escherichia coliR J Basaraba, A N Byerly, G C Stewart, et al.Inhalation Toxicology|October 5, 2012
Effects of outdoor air pollutants on platelet activation in people with type 2 diabetesMark W Frampton, Jan Bausch, David Chalupa, et al.Pageof 181